Verzenio
FDA Approves Verzenio for Early Breast Cancer
The FDA approved abemaciclib (Verzenio, Lilly) with endocrine therapy (tamoxifen or an aromatase inhibitor) for ...
OCTOBER 19, 2021
Abemaciclib Approved for Advanced HR-Positive/HER2-Negative Breast Cancer
With its FDA approval, abemaciclib (Verzenio, Lilly) has risen to the top of the cyclin-dependent kinase (CDK) 4/6 ...
OCTOBER 2, 2017
Load more